Position in GRFS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,826
-$198,433 QoQ
Shares Held
823
-96.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#134
of 164 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Integrated Wealth Concepts LLC holds $214,639,248 across 18 Drug Manufacturers - General names. GRFS ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
60,927 | $73,077,677 | |
| 2 | JNJ |
Johnson & Johnson
|
162,906 | $41,373,236 | |
| 3 | MRK |
Merck & Co., Inc.
|
162,596 | $20,893,586 | |
| 4 | ABBV |
AbbVie Inc.
|
78,969 | $19,871,759 | |
| 5 | PFE |
Pfizer Inc
|
613,403 | $14,770,744 | |
| 6 | AMGN |
Amgen Inc
|
35,828 | $12,974,035 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
222,207 | $12,803,567 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
40,048 | $5,059,664 |
All Filings in GRFS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,826 | 823 | Shares | Sole | 2026-08-12 | |
| 2025-09-30 | $204,259 | 20,508 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||